Tuesday, September 6, 2016

GSK's triple drug cuts flare-ups in chronic lung disease

LONDON, Sept 6 (Reuters) - An experimental three-in-one

inhaled drug from GlaxoSmithKline significantly cut

flare-ups in patients with chronic lung disease in a clinical

trial, researchers said on Tuesday.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)